GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » 3-Year EPS without NRI Growth Rate

Arch Biopartners (TSXV:ARCH) 3-Year EPS without NRI Growth Rate : 11.70% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners 3-Year EPS without NRI Growth Rate?

Arch Biopartners's EPS without NRI for the three months ended in Dec. 2023 was C$-0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 11.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was -20.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Arch Biopartners was 70.10% per year. The lowest was -461.50% per year. And the median was 12.80% per year.


Competitive Comparison of Arch Biopartners's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Arch Biopartners's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Biopartners's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's 3-Year EPS without NRI Growth Rate falls into.



Arch Biopartners 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Arch Biopartners  (TSXV:ARCH) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Arch Biopartners 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Arch Biopartners (TSXV:ARCH) Business Description

Industry
Traded in Other Exchanges
N/A
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.